These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 428228)

  • 21. The hazards of vacuum aspiration in late first trimester abortions.
    Moberg P; Sjöberg B; Wiqvist N
    Acta Obstet Gynecol Scand; 1975; 54(2):113-8. PubMed ID: 1136716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T; Tabuchi T; Tabei T; Kaku R
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
    Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
    Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
    Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
    Somell C; Olund A
    Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
    Slade P; Heke S; Fletcher J; Stewart P
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
    Urquhart DR; Templeton AA
    Br J Obstet Gynaecol; 1991 Apr; 98(4):396-9. PubMed ID: 2031899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilatation of the cervix prior to vacuum aspiration by single vaginal administration of 15-methyl-PGF2 alpha methyl ester.
    Frankman O; Bygdeman M; Gréen K; Moberg P; Sandberg CG
    Contraception; 1980 Jun; 21(6):571-6. PubMed ID: 7428365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
    Cameron IT; Baird DT
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?
    Platz-Christensen JJ; Nielsen S; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):809-12. PubMed ID: 8533565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the efficacy of gemeprost vaginal pessaries and extra-amniotic prostaglandin E2 gel in the induction of middle trimester abortion.
    Bigrigg A; Bourne T; Read MD
    J Obstet Gynaecol (Lahore); 1990 Apr; 10(4):304-5. PubMed ID: 12283426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin analogues and their uses.
    Bygdeman M
    Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):893-903. PubMed ID: 1478002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.